Classifying Fibromyalgia Syndrome as a Mental Disorder?—An Ambulatory Assessment Study

Klaus, Kristina; Fischer, Susanne; Doerr, Johanna M.; Nater, Urs M.; Mewes, Ricarda

doi:10.1007/s12529-016-9603-6

Cited by 18 publications

(14 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a smaller ambulatory study of fibromyalgia patients, 38.5% fulfilled the A-and B-criteria of SSD (Klaus et al, 2017). In a study assessing somatic conditions in patients with SSD, 28.8% had asthma, 23.1% had a circulatory condition, and 13.5% had gout, rheumatism or arthritis (Newby et al, 2017).…”

Section: Psychological Medicine 11mentioning

confidence: 98%

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis

et al. 2021

View full text Add to dashboard Cite

Background In 2013, the diagnosis of somatic symptom disorder (SSD) was introduced into the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). This review aims to comprehensively synthesize contemporary evidence related to SSD. Methods A scoping review was conducted using PubMed, PsycINFO, and Cochrane Library. The main inclusion criteria were SSD and publication in the English language between 01/2009 and 05/2020. Systematic search terms also included subheadings for the DSM-5 text sections; i.e., diagnostic features, prevalence, development and course, risk and prognostic factors, culture, gender, suicide risk, functional consequences, differential diagnosis, and comorbidity. Results Eight hundred and eighty-two articles were identified, of which 59 full texts were included for analysis. Empirical evidence supports the reliability, validity, and clinical utility of SSD diagnostic criteria, but the further specification of the psychological SSD B-criteria criteria seems necessary. General population studies using self-report questionnaires reported mean frequencies for SSD of 12.9% [95% confidence interval (CI) 12.5–13.3%], while prevalence studies based on criterion standard interviews are lacking. SSD was associated with increased functional impairment, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Relevant research gaps remain regarding developmental aspects, risk and prognostic factors, suicide risk as well as culture- and gender-associated issues. Conclusions Strengths of the SSD diagnosis are its good reliability, validity, and clinical utility, which substantially improved on its predecessors. SSD characterizes a specific patient population that is significantly impaired both physically and psychologically. However, substantial research gaps exist, e.g., regarding SSD prevalence assessed with criterion standard diagnostic interviews.

show abstract

Section: Psychological Medicine 11mentioning

confidence: 98%

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…During the COVID-19 pandemic, in addition to fibromyalgia, a variety of secondary factors such as age, female gender, low level of education, poor sleep quality, marital status, financial status, and loneliness affected pa-tients' mental health (17)(18)(19)(20)(21)(22)(23)(24)(25). For this reason, in addition to the mental health of fibromyalgia patients, it is necessary to pay further attention to the individual differences and lifestyle of these patients to promote the psychological health of fibromyalgia patients during the COVID-19 pandemic (14)(15)(16).…”

Section: Discussionmentioning

confidence: 99%

“…Studies conducted during the COVID-19 pandemic indicate a higher prevalence of fibromyalgia symptoms in patients (14), and it is expected that in the post-COVID-19 period, we will see a significant growth of this chronic disease worldwide (15,16). Various studies indicate a high prevalence of mental disorders in patients with fibromyalgia (17,18). Stress and anxiety are the most common psychological comorbidities in patients with fibromyalgia.…”

Section: Contextmentioning

confidence: 99%

Psychological Consequences of Coronavirus 2019 Pandemic in Fibromyalgia Patients: A Systematic Review Study

Sheykhangafshe

Farahani

Azadfallah

2021

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

Context: Fibromyalgia is a debilitating syndrome characterized by scattered and multifaceted musculoskeletal pain, the presence of multiple and unstable points sensitive to pain, sleep disturbance, fatigue, and muscle inflexibility, which were damaged during mental health by the COVID-19 pandemic. In this regard, the present review study was conducted to investigate the psychological consequences of the COVID-19 pandemic in patients with fibromyalgia. Data Sources: In this review study, published articles on the psychological consequences of the COVID-19 pandemic in fibromyalgia patients in 2020 (February) and 2021 (July) were reviewed. To access relevant scientific documents, the keywords COVID-19, Chronic Pain, Fibromyalgia, Mental Health, Chronic Illness, and Psychological Anxiety in the titles and abstracts of articles published in reputable international scientific databases, such as Google Scholar, PubMed, Science Direct, Scopus, EMBASE, and PsycINFO, were searched and all related English-language articles were listed. Results: The studies showed that patients with fibromyalgia had high levels of depression, anxiety, stress, and fear during the COVID-19 pandemic. Variables such as age, gender, low level of education, sleep quality, marital status, financial status, and loneliness were associated with psychological distress and the exacerbation of symptoms in fibromyalgia patients. In contrast, social support and the use of effective coping strategies led to improved quality of life and mental health of patients. Conclusions: According to the results of studies, patients with chronic pain, including fibromyalgia patients during the COVID-19 pandemic, experienced problems in mental health, quality of life, social relationships, and sleep quality, which caused recurrence of the disease and increased anxiety and depression in them.

show abstract

“…28 There have been recent publications that classify FM as an SSD. 29,30 However, in one study, only 26% of FM patients met the criteria for an SSD. The construct validity and the clinical utility of the diagnostic label SSD were limited in this study.…”

Section: Fibromyalgia Is a Somatic Symptom Disordermentioning

confidence: 97%

Facts and myths pertaining to fibromyalgia

Haüser

Fitzcharles

2018

Dialogues in Clinical Neuroscience

150

View full text Add to dashboard Cite

Fibromyalgia (FM) is characterized by chronic widespread pain, unrefreshing sleep, physical exhaustion, and cognitive difficulties. It occurs in all populations throughout the world, with prevalence between 2% and 4% in general populations. Definition, pathogenesis, diagnosis, and treatment of FM remain points of contention, with some even contesting its existence. The various classification systems according to pain medicine, psychiatry, and neurology (pain disease; persistent somatoform pain disorder; masked depression; somatic symptom disorder; small fiber neuropathy; brain disease) mostly capture only some components of this complex and heterogeneous disorder. The diagnosis can be established in most cases by a general practitioner when the symptoms meet recognized criteria and a somatic disease sufficiently explaining the symptoms is excluded. Evidence-based interdisciplinary guidelines give a strong recommendation for aerobic exercise and cognitive behavioral therapies. Drug therapy is not mandatory. Only a minority of patients experience substantial symptom relief with duloxetine, milnacipran, and pregabalin.

show abstract

Classifying Fibromyalgia Syndrome as a Mental Disorder?—An Ambulatory Assessment Study

Abstract: FMS might be diagnosed as a mental disorder according to DSM-5 in many cases. SSD symptoms proved to have predictive value for FMS severity and may thus have clinical relevance for diagnostic, prognostic, and intervention purposes.

Cited by 18 publications

References 45 publications

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis

Psychological Consequences of Coronavirus 2019 Pandemic in Fibromyalgia Patients: A Systematic Review Study

Facts and myths pertaining to fibromyalgia

Contact Info

Product

Resources

About